BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+16.43%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.58B
AUM Growth
+$1.58B
(+34%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
14.78%
Top 10 Holdings %
Top 10 Hldgs %
32.67%
Holding
149
New
11
Increased
79
Reduced
34
Closed
11
Top Buys
| 1 |
Abbott
ABT
|
$14.5M |
| 2 |
Pacific Biosciences
PACB
|
$13.9M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$10.2M |
| 4 |
CareDx
CDNA
|
$9.72M |
| 5 |
Medtronic
MDT
|
$9.3M |
Top Sells
| 1 |
DexCom
DXCM
|
$28.5M |
| 2 |
Bausch Health
BHC
|
$3.02M |
| 3 |
Amgen
AMGN
|
$2.27M |
| 4 |
Gilead Sciences
GILD
|
$1.76M |
| 5 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$1.67M |
Sector Composition
| 1 | Healthcare | 93.18% |
| 2 | Industrials | 1.09% |
| 3 | Technology | 0.34% |
| 4 | Financials | 0.09% |
